Carlisle Companies CSL
$378.85 −$9.06 (-2.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $378.85 0.00%
Open$391.91
Prev close$387.91
Day range$377.41 – $395.90
Volume381.4K
Market cap$14.64B
P/E (TTM)21.4
Dividend yield1.20%
CSL Stock News
Headlines matching Carlisle Companies or the CSL ticker, most recent first.
- CSL Target Price Raised 31% to A$174.00/Share by MacquarieCSL.AU Positive
- Morgan Stanley Maintains CSL LTD(CMXHF.US) With Buy Rating, Cuts Target Price to $123.25 Negative
- UBS Maintains CSL LTD(CMXHF.US) With Buy Rating, Maintains Target Price $129.7
- CSL Raised to Accumulate From Hold by Ord Minnett CSL.AU Positive
- RBC Capital Upgrades CSL LTD(CMXHF.US) to Buy Rating, Raises Target Price to $152.48 Positive
- Morgans Maintains CSL LTD(CMXHF.US) With Buy Rating, Cuts Target Price to $134.13 Negative
- CSL Ltd: Agreements with U.S. on Drug Prices and Manufacturing
- D.A. Davidson Maintains Carlisle Companies(CSL.US) With Hold Rating, Raises Target Price to $410 Positive
- Goldman Sachs Maintains Carlisle Companies(CSL.US) With Buy Rating
- A Quick Look at Today's Ratings for CSL LTD(CMXHF.US), With a Forecast Between $113.89 to $147.34
- A Quick Look at Today's Ratings for CSL LTD(CMXHF.US), With a Forecast Between $113.21 to $132.82
- CSL Price Target Raised 15% to A$181.00/Share by UBS Positive
- CSL Price Target Raised 25% to A$150.00/Share by Bell Potter Positive
- CSL Price Target Raised 23% to A$146.50/Share by Jefferies Positive
- UBS Maintains CSL LTD(CMXHF.US) With Buy Rating, Cuts Target Price to $111.83 Negative
No comments yet — be the first to weigh in on CSL.
Sign in to join the discussion.